raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:555407

NAD(P)HX epimerase deficiency

Synonyms: Apolipoprotein A-I binding protein deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy
Status
active

A rare neurometabolic disease characterized by infantile onset of rapidly progressive neurological deterioration, typically precipitated by a febrile illness. Patients present with hypotonia, loss of previously acquired motor milestones and cognitive skills, ataxia, nystagmus, tremor, seizures, tetraparesis, and respiratory failure, eventually resulting in a vegetative state. Imaging of the brain and spinal cord may show white matter abnormalities, cerebral atrophy, cerebellar edema, and spinal myelopathy. Subacute development of extensive bullous skin lesions within weeks of onset of neurological symptoms has also been reported.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enNAD(P)HX epimerase deficiencyApolipoprotein A-I binding protein deficiency
frDéficit en NAD(P)HX épiméraseDéficit en protéine de liaison apolipoprotéine A-I
deNAD(P)HX-Epimerase-MangelApolipoprotein A-I-Binding-Protein-Mangel
esDeficiencia de NAD(P)HX epimerasaDeficiencia de proteína de unión apolipoproteína A-I
itDeficit di NAD(P)HX epimerasi
nlNAD(P)HX-epimerasedeficiëntieDeficiëntie van apolipoproteïne A-I-bindingsproteïne
ptDeficiência de NAD(P)HX epimerase
plNiedobór epimerazy NAD(P)HX= en
csDeficit NAD(P)HX epimerázyDeficit vazebného proteinu apolipoproteinu A-I
ukДефіцит епімерази NAD(P)HXДефіцит аполіпопротеїну A-I, що звязує білок
zhNAD(P)HX表表异构酶缺乏载脂蛋白A-I结合蛋白缺乏
trNAD (P) HX epimeraz eksikliğiApolipoprotein A-I bağlayıcı protein eksikliği

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM617186Evalidated
ICD-10E88.8NTBTattributedvalidated
ICD-115C5YNTBTattributedvalidated
MONDO0020781Evalidated
UMLSC4310675Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (4):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
NAXEDisease-causing germline mutation(s) inAssessedHGNC:18453ENSG000001633826088621q22NAD(P)HX epimerase27616477[PMID]_27122014[PMID]_29884839[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families11 casesWorldwideCase(s)Validated27616477[PMID]_27122014[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_27616477[PMID]_27122014[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

27 annotations · validated 2026-01-14
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0001251Ataxia
Frequent (79-30%)
HP:0001289Confusion
HP:0002376Developmental regression
HP:0001260Dysarthria
HP:0002015Dysphagia
HP:0011203EEG with abnormally slow frequencies
HP:0001288Gait disturbance
HP:0030890Hyperintensity of cerebral white matter on MRI
HP:0001252Hypotonia
HP:0002490Increased CSF lactate
HP:0002878Respiratory failure
HP:0001250Seizure
HP:0001337Tremor
Occasional (29-5%)
HP:0000739Anxiety
HP:0000708Atypical behavior
HP:0012444Brain atrophy
HP:0001272Cerebellar atrophy
HP:0002181Cerebral edema
HP:0002352Leukoencephalopathy
HP:0011355Localized skin lesion
HP:0002196Myelopathy
HP:0001336Myoclonus
HP:0000639Nystagmus
HP:0000508Ptosis
HP:0002650Scoliosis
HP:0001257Spasticity
HP:0000486Strabismus

Run the differential on the 1 obligate / very frequent terms

Annotation source: 34678889[PMID]_35637064[PMID]_38419707[PMID]

7

Sources for this card